You searched for "PDS"
Business recovery and relaunch: how to grow your patient base in the new economy
As the unprecedented impact of the COVID-19 pandemic continues to be felt, many aesthetic practitioners are facing an uncertain future. In this invaluable article Pam Underdown provides expert advice on how to survive and grow stronger than ever. The global...
Essentials of Plastic Surgery: Q&A Companion
This excellent second edition of Q&A Companion of the very well-established Essentials of Plastic Surgery by Dr Jeffrey Janis provides a complete and detailed overview of the entire plastic surgery syllabus. All material is up-to-date and has been written as...How I Do It - Approaches to acne treatment: Pulsed-dye laser
Acne vulgaris is the most common skin disease worldwide and inflammatory acne has significant psychological impact with potential for long-term emotional and physical sequelae [1]. Energy based treatments are useful both as adjuncts to traditional therapies and particularly for patients...The International Society of Aesthetic Plastic Surgery ISAPS Releases Statistics on Cosmetic Procedures Worldwide
There is a whole range of interesting statistics produced by the ISAPS latest survey. It provides a breakdown of the 23 million cosmetic procedures that were carried out worldwide in 2013 both by country and type of procedure. Look at...Intraline KOL appointment
Intraline Medical Aesthetics is thrilled to announce the appointment of aesthetic doctors, Dr. Simon Zokaie and Dr. Mark Holmes, as Key Opinion Leaders for the Intraline portfolio of medical aesthetic products.Cutera Redefines the Muscle Sculpting Market with US Commercial Launch of truSculpt® flex
CUTERA, INC., a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announced today the U.S. limited commercial launch of truSculpt® flex, the Company’s new muscle sculpting platform.Recurrent corneal erosions secondary to isotretinoin use
This article originally appeared in Eye News Dec/Jan 2021 Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations,...Non-surgical management of actinic keratosis, Bowen’s disease and non-melanoma skin cancer
Non-melanoma skin cancers (NMSCs) are primary cutaneous neoplasms comprising mainly of basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs). In 2011, 102,628 cases of NMSCs (74% BCC and 23% SCC) were recorded in England, making NMSC the most common...Croma-Pharma completed the decentralized procedure for its botulinum toxin to treat glabellar (frown) lines
Croma’s botulinum toxin submission in Europe is based on the data of 3 completed randomized, placebo-controlled phase III trials that enrolled a total of >1000 subjects in Europe and the US.
